Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLymphomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
November 26, 2025
 · 
Reactions
MyLymphomaTeam

What is the standard treatment for relapsed low-grade intestinal follicular lymphoma after previous DLBCL transformation?

When follicular lymphoma relapses after transforming to DLBCL, treatment options depend on several factors including your age, symptoms, which parts of your body are affected, how much the lymphoma has Show Full Answer

What is the standard treatment for relapsed low-grade intestinal follicular lymphoma after previous DLBCL transformation?

When follicular lymphoma relapses after transforming to DLBCL, treatment options depend on several factors including your age, symptoms, which parts of your body are affected, how much the lymphoma has grown, and your overall health.

For relapsed follicular lymphoma, common treatment approaches include:

* Targeted therapy drugs like lenalidomide (Revlimid), obinutuzumab (Gazyva), epcoritamab (Epkinly), or tazemetostat (Tazverik)
* Immunotherapy including monoclonal antibodies such as rituximab (Rituxan) and obinutuzumab (Gazyva), which can be used alone or with chemotherapy
* T-cell therapy such as epcoritamab-bysp (Epkinly), which helps T cells target and kill lymphoma cells
* Chemotherapy regimens combined with prednisone to reduce excessive B cells
* Bone marrow transplant may be considered, especially for younger patients, to replace damaged cells with healthy ones

For more aggressive situations, tafasitamab-cxix (Monjuvi) combined with lenalidomide and rituximab might be recommended.

Your oncologist will recommend second-line treatments based on what you've previously received and your current health status. Clinical trials may also provide access to newer treatment options still under development.

November 26, 2025

Related Questions

View All
A MyLymphomaTeam Member asked a question 💭
Moorestown, NJ